Cardiovascular pharmacology studies drugs that affect the heart and vascular system, focusing on the treatment of conditions like hypertension, arrhythmias, heart failure, and atherosclerosis. It covers agents such as beta-blockers, ACE inhibitors, calcium channel blockers, antiplatelet, and anticoagulants. Research investigates how these drugs influence cardiac function, vascular tone, and blood clotting. Advances in molecular cardiology and targeted therapies are improving patient outcomes and reducing side effects. Cardiovascular pharmacologists also study drug safety in high-risk populations, such as the elderly or patients with multiple comorbidities.
sub tracks:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
